Tillett Caroline, the Chief Scientific Officer of Kenvue Inc., recently reported stock transactions in an SEC filing dated October 6, 2026. This filing is notable as it reveals the acquisition of shares, which may indicate the executive's confidence in the company's prospects.
Kenvue Inc., incorporated in Delaware, operates in the perfumes, cosmetics, and other toilet preparations sector. The company has a Central Index Key (CIK) of 0001944048 and trades under the symbol KVUE. The recent filing is part of a series of disclosures, with the most recent prior filing being on March 4, 2026.
The filing details two significant transactions by Tillett on October 2, 2026. The first transaction involved the acquisition of 24,732 shares of common stock at a price of $17.20 per share. Following this transaction, Tillett owns a total of 86,180.15 shares. The second transaction included the acquisition of 8,471 shares, also at $17.20 per share, resulting in a total of 77,709.15 shares owned after this transaction.
“Represents the distribution of shares of common stock upon satisfaction of the performance criteria applicable to Performance Share Units (PSUs) granted on October 2, 2023,” the filing states.
Additionally, the filing notes that some shares were withheld for tax payments. This information is crucial for stakeholders as it reflects the executive's financial engagement with the company.
These transactions may affect Kenvue's shareholders and potential investors, as they demonstrate executive confidence in the company's performance and future growth. The cosmetics and personal care industry, in which Kenvue operates, is highly competitive, and such insider transactions can provide insights into company health and executive sentiment.
The filing does not specify what actions will follow these transactions, leaving stakeholders to monitor further developments closely.